Mounjaro (tirzepatide), manufactured by Eli Lilly, is included in the NAION-related MDL (No
Data from randomized controlled trials shows that most patients moods actually improve when treated for obesity with GLP-1 medications, according to Dr
The majority of previous studies suggest that cannabis use acutely stimulates appetite and food intake, while chronic cannabis use reduces the risk of obesity, insulin resistance, and diabetes mellitus 25,65,66,67,68
Presented for research literature review only Musser RE et al
Diabetes education Access to experienced and caring patient educators, plus diabetes management classes, patient handouts and web resources Eating healthy support Registered dieticians who teach patients how to identify and make healthy food choices Through our holistic approach, we help patients navigate the complexities of GLP-1 therapy, ensuring they achieve the best possible outcomes while minimizing potential side effects
And pay attention to the Beyond-Use Date (BUD) printed on your vial, which is different from the expiration date and tells you how long the opened vial remains safe for multi-dose use